ArticleJournal of pharmaceutical and biomedical analysis2019

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy.

Troy Wanandy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.